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AbstrACt
Objective To inform the development of a patient-reported 
outcome measure, the aim of this study was to identify 
which symptoms and feelings following percutaneous 
coronary intervention (PCI) are most important to patients.
Design Discrete-choice experiment consisting of two 
hypothetical scenarios of 10 symptoms and feelings 
(pain or discomfort; shortness of breath; concern/worry 
about heart problems; tiredness; confidence to do usual 
activities; ability to do usual activities; happiness; sleep 
disturbance; dizziness or light-headedness and bruising) 
experienced after PCI, described by three levels (never, 
some of the time, most of the time). Preference weights 
were estimated using a conditional logit model.
setting Four Australian public hospitals that contribute 
to the Victorian Cardiac Outcomes Registry (VCOR) and a 
private insurer’s claim database.
Participants 138 people aged >18 years who had 
undergone a PCI in the previous 6 months.
Main outcome measures Patient preferences via trade-
offs between 10 feelings and symptoms.
results Of the 138 individuals recruited, 129 (93%) 
completed all 16 choice sets. Conditional logit parameter 
estimates were mostly monotonic (eg, moving to worse 
levels for each individual symptom and feeling made the 
option less attractive). When comparing the magnitude of 
the coefficients (based on the coefficient of the worst level 
relative to best level in each item), feeling unhappy was 
the symptom or feeling that most influenced perception 
of a least-preferred PCI outcome (OR 0.42, 95% CI 0.34 to 
0.51, p<0.0001) and the least influential was bruising (OR 
0.81, 95% CI 0.67 to 0.99, p=0.04).
Conclusion This study provides new insights into how 
patients value symptoms and feelings they experience 
following a PCI.
IntrODuCtIOn  
Worldwide, coronary artery disease (CAD) is 
the leading cause of death, and will continue 
to be until at least 2030.1 Percutaneous 
coronary intervention (PCI) and coronary 
artery bypass graft (CABG) surgery are 
among the most common major medical 
procedures performed in North America, 
Europe and the UK.2 3 While PCI is less inva-
sive than CABG, long-term benefits over 
optimal medical management for patients 
with chronic stable CAD remain unknown.4 
The effectiveness of PCI is also questionable 
in terms of quality of life and cost bene-
fits if repeat revascularisation is required, 
and in patients with multivessel disease.5–9 
Measuring patient-reported outcomes may 
provide greater insight into the health and 
well-being of patients following PCI.
There is growing recognition that under-
standing outcomes from the view of the 
patient, rather than relying on clinical 
end points alone, offers the potential to 
improve cardiac care.10 11 The International 
Consortium for Health Outcomes Measure-
ment (ICHOM) Standard Set for CAD has 
identified five outcomes that matter most to 
patients with CAD: (1) health-related quality 
of life; (2) functional status; (3) depression; 
strengths and limitations of this study
 ► This study design used a discrete-choice experiment 
(DCE), which quantifies the relative value as well as 
order of importance of each individual symptom and 
feeling, unlike simple ranking methods.
 ► There was no correlation between individual symp-
toms and feelings or overlap between scenarios as 
the DCE design was orthogonal and balanced.
 ► Interaction effects cannot be accurately estimated 
as the study design selected choice sets assuming 
an additive model.
 o
n
 14 January 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023141 on 18 October 2018. Downloaded from 
2 Barker AL, et al. BMJ Open 2018;8:e023141. doi:10.1136/bmjopen-2018-023141
Open access 
(4) dyspnoea and (5) angina.12 It recommends three 
patient reported outcome measures (PROMs) totalling 
11 items be used with patients with CAD to measure these 
outcomes. While these recommendations are based on 
advice from a group of leading physicians, measurement 
experts and patients, the number of items across different 
instruments is likely to limit uptake. A more concise, 
single tool may be developed to improve clinical utility 
and decreases respondent burden.
PROMs quantify information about the symptoms and 
feelings a patient is experiencing, providing insights 
into their overall health state. PROMs seek informa-
tion directly from patients without interpretation of 
their response by a clinician or anyone else. They are 
used to assess treatment effectiveness and are a tool to 
improve the quality of clinician-patient interactions, 
facilitating shared decision-making and patient-centred 
care.13 Their use is recommended in clinical trials of 
interventions for patients with cardiovascular disease by 
key stakeholders including the American Heart Associa-
tion14 15 and is a requirement of health service funders 
in the UK and the USA.16 Cardiovascular registries focus 
on improving quality of care by reporting process and 
outcome measures. The most commonly collected and 
reported outcomes are in-hospital and 30-day mortality 
and complications.12 Some collect generic quality of life 
measures but cardiac-specific PROMs are not routinely 
collected. The length of existing cardiac PROMs (up to 
160 items)17 18 may be a key factor in their limited uptake. 
In addition, a previous review highlighted that the patient 
perspective had often been overlooked in the develop-
ment of PROMs for patients who had undergone elective 
coronary revascularisation.17 As such, instruments were 
not necessarily reflective of outcomes most important to 
patients, including only two of the three PROMs recom-
mended by ICHOM.12 19
One method for obtaining quantitative information 
about patient perspectives is via a discrete-choice experi-
ment (DCE). DCEs involve respondents making choices 
in reply to a series of hypothetical scenarios. For example, 
a respondent is presented with two health profiles 
(scenario A and scenario B), which have varying levels 
of symptoms (eg, no pain, some shortness of breath, 
severe bruising vs severe pain, no shortness of breath, 
no bruising), and the respondent selects which health 
profile they would prefer. The participant responds to a 
series of paired scenarios with varying combinations of 
symptoms. The design and analysis provides information 
on trade-offs that the respondents are willing to make for 
different symptoms, for example, how much pain would a 
patient be willing to endure to experience less shortness 
of breath. As such, DCEs go beyond ranking exercises 
by providing information on relative strength of prefer-
ence and trade-offs. Additionally, they enable interactions 
between respondent characteristics and outcomes to be 
explored and provide an in-depth assessment of prefer-
ences.20 DCEs have not previously been applied in the 
development of cardiac PROMs.
In addition to response burden and a lack of patient 
involvement in the design and development of existing 
cardiac PROMs, generic quality of life instruments may 
have measurement flaws when applied to PCI popu-
lations. By example, the Victorian Cardiac Outcomes 
Registry (VCOR) collects the 5-item Euroqol (EQ-5D) at 
the 30-day telephone follow-up of patients undergoing 
PCI.21 Analysis of data shows that at 30 days post proce-
dure, approximately 80% of patients report having no 
problems with personal care, mobility, usual activities, 
pain/discomfort or anxiety/depression.22 This suggests 
that either patients are generally feeling and doing well 
after PCI, or more likely, that the EQ-5D has a ceiling 
effect in the PCI population. An opportunity exists to 
develop a new PROM for patients undergoing PCI that is 
based on patient perspective, is concise, useable and has 
sound measurement properties.
The primary aim of this study was to quantify the impor-
tance of symptoms and feelings commonly experienced 
by patients following PCI, using a DCE to inform the 
development of a PROM.
Specifically, the objectives were to:
1. Elicit relative value of each symptom and feeling in-
cluding trade-offs;
2. Examine patient characteristics that could influence 
the perceived value of each symptom and feeling and
3. Provide recommendations for symptoms and feelings 
that could be included in a new PROM.
MethODs
This study was step 3 of a larger project that aimed to 
develop a PROM for patients undergoing PCI (figure 1).
The results from steps 1 and 2 were considered in the 
designing of the DCE, to inform:
1. The symptoms and feelings of interest (literature re-
view, focus groups and interviews) and
2. Setting levels for symptoms and feelings (literature re-
view, focus groups and interviews; expert opinion).
Literature review, focus groups and interviews (steps 1 and 2)
A systematic search of the peer-reviewed literature was 
undertaken to identify existing cardiac PROMs.17 Twen-
ty-seven PROMs were identified yielding 430 symptoms 
and feelings that were used to develop topic guides for 
the focus groups and interviews. Further details on the 
methods and results of the literature review have been 
published elsewhere (refer to Peeters et al17).
Eight focus groups (n=27) and five one-one interviews 
were conducted with people aged ≥18 years who had 
undergone a PCI in the last 6 months. Sessions explored: 
(1) the relevance and importance of symptoms and 
feelings identified from the literature review and (2) 
additional symptoms and feelings not identified by the 
search. They were semi-structured, and followed a topic 
guide to stimulate discussion about symptoms and feel-
ings that were important to patients and identify the 
potential range of variation in each symptom and feeling 
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(levels). Example levels were presented and their appro-
priateness discussed. The range of levels of each item 
was intended to: (1) span the clinically relevant range of 
symptoms and feelings that has been seen, or might be 
expected to be seen, in clinical trials or clinical practice; 
(2) ensure differences in levels encompass the range of 
improvements in symptoms and feelings that potentially 
could be seen in clinical trials or clinical practice and (3) 
reflect the maximum range over which respondents are 
willing to accept trade-offs among symptoms and feelings. 
Further details on the methods and results from these 
focus groups and interviews have been published else-
where (refer to Ayton et al23). Ten symptoms and feelings 
with a 3–4 level response option were confirmed as being 
most important to patients. These results were presented 
to an expert panel (consisting of cardiologists, nurses, 
health services researchers and allied health profes-
sionals), who agreed on the symptoms and feelings identi-
fied and the assignment of three levels to each symptom/
feeling (table 1).
Construction of choice sets
It was not feasible to present an individual with all 
possible combinations from the 10 symptoms and feel-
ings with three levels in table 1 (full factorial design: 
310=59 049 combinations). Therefore, experimental 
design techniques were used to draw a subset of symptom 
and feeling combinations to be used in the DCE. We 
employed NGENE (V.1.1.2) to develop the design. We 
developed a candidate set of choice sets, where any 4 of 
the 10 symptoms and feelings were constrained to be the 
same between the two options (and as shown in figure 2, 
the symptoms and feelings that do differ are highlighted 
to demonstrate differences between options). We then 
constructed a D-efficient design (i.e., identified a subset 
of the full-choice design) from those candidate choice 
sets.20 In addition to the assumption about the degree of 
overlap, we also excluded certain pairwise combinations 
of levels to ensure implausible combinations were not 
used.24 The implausible combination we excluded was 
feeling short of breath most of the time when exerting 
Figure 1 A four-step mixed-methods approach to develop and validate a new cardiac patient-reported outcome measure 
(PROM).
Table 1 Final set of symptoms and feelings and levels for the discrete choice experiment
Item Level 1 (worse) Level 2 Level 3 (better)
Pain or discomfort when exerting (eg, carrying groceries, 
climbing, stairs, brisk walking)
Most of the time Some of the time Never
Shortness of breath when exerting (eg, carrying groceries, 
climbing stairs, brisk walking)
Most of the time Some of the time Never
Concerned or worried about heart problem Most of the time Some of the time Never
Tiredness when doing usual activities (eg, work, social 
activities, domestic work)
Most of the time Some of the time Never
Lacking confidence to do usual activities (eg, work, social 
activities domestic work)
Most of them Some of the time Never
Physically unable to do usual activities (eg, work, social 
activities, domestic work)
Most of the time Some of the time Never
Feeling unhappy Most of the time Some of the time Never
Trouble falling or staying asleep Most of the time Some of the time Never
Dizziness or light-headedness Most of the time Some of the time Never
Bruising Most of the time Some of the time Never
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yourself (eg, carrying groceries, climbing stairs, brisk 
walking) but never physically unable to complete usual 
activities (eg, work, social activities, domestic work).
The final design consisted of 240 choice sets, from 
which each respondent was randomly assigned to one of 
15 versions which consisted of a block of 16 choice sets. 
The resulting design was nearly orthogonal and balanced 
in terms of the number of times each level of an item was 
seen in a scenario. The final design is reported in online 
supplementary appendix 1. To avoid confusion with 
participants, the choice sets were labelled as ‘scenario A’ 
and ‘scenario B’. For each choice set, the respondent was 
asked which scenario they would prefer to experience 
1 month after having a PCI. An example of a choice task 
is shown in figure 2.
survey design and pilot testing
The survey contained two components. Section 1 
included 11 demographic questions on characteristics 
of respondents (sex, age, living status, education, comor-
bidities, heart disorders, emergency/elective PCI, date 
of procedure) used to assess the representativeness of 
the sample against VCOR.21 Section 1 also included 11 
general health questions. Section 2 was the DCE survey as 
described above.
Once developed, the survey was pilot tested with eight 
patients undergoing PCI through one-one interviews. 
These patients had initially expressed interest in partici-
pating in interviews or focus groups for the prior stage of 
this research; however, they were unable to participate at the 
required time. Patients who had indicated that they were 
willing to be later contacted for the DCE component of the 
research were contacted to participate in the pilot testing of 
the survey. The results were used to establish a dissemination 
approach (paper version and online version) and refine 
the comprehension and wording of the survey. During the 
interviews, a researcher asked patients to ‘think aloud’ as 
they completed the survey, while the researcher observed. 
Once completed, patients were asked a series of debriefing 
questions to determine the feasibility of completing the 
survey; whether they understood the DCE questions and 
instructions and if any relevant symptoms and feelings were 
omitted. After each participant interview, changes to the 
DCE were made based on patient comments and tested in 
the subsequent interview. The final two pilot patients raised 
no issues with the survey.
study sample
In accounting for the number of choice sets, alternatives 
and analysis cells, the equation of Johnson and Orme25 
was used to calculate a required sample size of 46. A 
review undertaken by de Bekker-Grob et al26 found that 
41% (n=69) of health-related studies using DCE analysis 
had a sample size of 100–300. Therefore, we aimed to 
obtain 100–150 returned survey responses.
Participant recruitment
Our study sample included cardiac patients aged ≥18 years 
who had undergone a PCI in the previous 6 months; there 
were no exclusion criteria. Potential participants were 
Figure 2 Example choice set of the discrete choice experiment. Each participant was presented with 16 different choice sets. 
Six of the 10 dimensions differed between scenarios in each choice set and that these were highlighted in blue so that the 
participant could easily identify differences between scenarios.
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identified by review of hospital records from four Austra-
lian hospitals; and a private insurer’s claim database. A 
participant information sheet and letter with a link to 
the online survey were sent out to potential participants. 
Hardcopy surveys were sent to participants on request. 
Hardcopy surveys were also distributed at cardiac reha-
bilitation sessions run by one of the hospitals. Data collec-
tion took place between October 2016 and May 2017. No 
identifying information was collected. Completion and 
return of the survey implied consent.
Analysis
We assessed the representativeness of the sample rela-
tive to the VCOR population with Χ2 tests for categorical 
characteristics and a t-test for continuous character-
istics. Choice data were analysed using a conditional 
logit model. These regression models are commonly 
used when the dependent variable is binary such as 
for a choice—an individual’s preference for A or B.27 
To obtain robust variance estimates and account for 
the possible correlation of non-independent responses 
to the 16 scenarios presented to each individual, we 
applied Stata’s cluster-correlated robust estimate of 
variance. In this model, the dependent variable was the 
choice; the explanatory variables included the levels of 
the individual symptoms and feelings shown in table 1. 
All analyses were conducted using Stata IC V.14. In 
interpreting the regression results, the sign of the coef-
ficient reflected whether the dimension had a positive 
or a negative effect on preference compared with the 
base level. Since this base was never having the symptom 
or feeling, we expected a priori for coefficients to be 
negative due to the negative wording of symptoms and 
feelings (eg, pain most of the time was expected to have 
been a less preferred outcome than never having pain). 
To infer relative importance of each of the individual 
symptoms and feelings to participants, the magnitude of 
the coefficients (based on the worst level relative to the 
best level) were compared.
To explore heterogeneity of response scale, whereby 
responses may vary due to non-observable participant 
characteristics, we employed a heteroscedastic condi-
tional logit model.27 Analyses included categorical covari-
ates (such as age, emergency procedure and sex) in the 
model one by one. For this, age was divided into two 
categories (70 years and over or under 70), emergency 
procedure (yes or no) and sex (female or male). Statisti-
cally significant covariates (defined as p<0.05) were then 
included and non-significant covariates were excluded 
from this model. The value of accounting for how much 
covariates affected the model fit was tested using Akaike 
information criterion (AIC), and the complimentary 
Bayesian information criterion (BIC). The results from 
the analysis were presented to a group of clinical experts 
(cardiologists, cardiac nurse, VCOR registry members, 
health services managers) to ensure clinical applicability 
and acceptability.
Patient involvement
Patients were not directly involved in the development 
of the research questions, study design or conduct. A lay 
summary of our findings from this and all studies from 
this project will be available for VCOR participants and 
the public at https:// vcor. org. au.
resuLts
Patient characteristics
A total of 1056 surveys were distributed to potential 
participants; 1032 surveys via post and 24 distributed 
at cardiac rehabilitation sessions. A total of 139 surveys 
were returned representing a response rate of 13%. 
One survey was excluded (recruited via the private 
health insurer) as the patient had a CABG and not a 
PCI. All patients started the first DCE choice set and 
129 (93 %) completed all 16 choice sets, with a total of 
138 surveys included in the analysis.
Of the 138 patients, the majority were male (n=102; 
74%); and were aged under 70 years (n=75, 54%). 
Seventy were retired (51%). For 70% of patients 
(n=96), this was their first stent procedure; and 34% 
of these were an elective procedure (n=47). Demo-
graphics and self-reported health characteristics are 
presented in table 2. The study sample is representative 
of the patient demographics from the VCOR in relation 
to sex (77% male), age (mean 66, SD 12.0), recurrent 
PCI (32.7%), emergency procedure (60%) and elective 
procedure (36%).21
Objective 1: eliciting relative value of each symptom and 
feeling and trade-offs
The results for the conditional logit model are reported 
in table 3. There is a logical ordering of levels within 
the majority of symptoms and feelings—monotonic 
construction (ie, moving to worse levels in each indi-
vidual symptom and feeling made the option less attrac-
tive) (table 2). Each movement away from the ‘never’ 
level (level 1) for each item is negative and absolutely 
larger, except level 2 for tiredness, shortness of breath and 
bruising. However, these non-monotonicities (non-log-
ical ordering of levels) were not statistically significant. 
Out of a possible 20 coefficients, 12 are statistically 
significant in the model. Both levels 2 and 3 were 
statistically significant for three symptoms and feelings 
(pain, lacking confidence to do usual activities and trouble 
falling asleep).
When comparing the magnitude of the coefficients 
to infer relative importance of the item to participants 
(based on the worst level relative to the best level), the 
most important item was feeling unhappy (OR 0.42, 95% CI 
0.34 to 0.51, p<0.0001). The negative coefficient indicates 
feeling unhappy was the symptom or feeling that most 
influenced perception of a least-preferred PCI outcome. 
Next important were physically being able to do daily activ-
ities (OR 0.48, 95% CI 0.39 to 0.6, p<0.0001) and least 
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important was bruising (OR 0.81, 95% CI 0.67 to 0.99, 
p=0.04).
Objective 2: examining patient characteristics that could 
influence the perceived value of each symptom and feeling
Age (under 70 vs 70 years and older), sex and procedure 
type (emergency vs elective) were added to the model 
one by one. Age and sex were statistically significant 
covariates (p<0.05). However, there was no statistically 
significant variation in item preferences between elec-
tive and emergency patient groups (p=0.45). Figure 3 
shows the relative importance of each of the items for 
the unadjusted and adjusted (adjusted for age and sex) 
models. In general, the coefficients of the two models 
are similar. Of note, the AIC and BIC (tests for best 
model fit) were both slightly reduced when accounting 
for age and sex in the model (indicating the adjusted 
model is considered to be a better fit model).
Objective 3: recommended symptoms and feelings to be 
included in a PrOM
The ORs for each of the symptoms and feelings was 
presented to the clinical expert group. The clinical 
experts felt that bruising could be removed as an item; 
however, shortness of breath should be included as it is an 
important clinical indicator of recovery. The coefficients 
for tiredness (OR 0.61, 95% CI 0.51 to 0.73, p<0.0001) and 
trouble falling asleep or staying asleep (OR 0.59, 95% CI 0.49 
to 0.71, p<0.0001) were the next least important. In addi-
tion, it is possible that there may be interaction in prefer-
ences for these two symptoms and feelings, as they may 
be measuring similar constructs. Hence, we deferred to 
the results from the focus groups and interviews (step 2, 
figure 1), where participants described how their medi-
cations post-PCI impacted on sleep quality which led to 
feelings of tiredness and fatigue.23 Therefore, it was recom-
mended, to retain only trouble falling asleep or staying asleep. 
The clinical expert group recommendations resulted in a 
final set of eight symptoms and feelings for future assess-
ment of a PROM for patients undergoing PCI.
DIsCussIOn
In this study, eight symptoms and feelings were iden-
tified as being important to patients undergoing PCI, 
compared with the ICHOM recommended 11 items 
from three separate cardiac PROMs, highlighting the 
potential for a new briefer cardiac PROM. The most 
important symptoms and feelings to patients following 
a PCI were feeling unhappy, followed by physically being 
able to do usual activities. The least important was bruising. 
There was some overlap between symptoms and feelings 
identified as most important to patients with CAD by 
ICHOM and this study, specifically feeling unhappy, phys-
ically being able to do usual activities, pain and discom-
fort on exertion and shortness of breath. However, this 
study identified additional symptoms and feelings as 
important—sleep difficulties, dizziness, confidence to do 
usual activities and concern or worry about heart prob-
lems. These findings suggest that there is opportunity to 
improve the measurement of patient-reported outcomes 
in patients undergoing PCI by incorporating the findings 
from this study. Further analysis will confirm which of the 
eight items have sound measurement properties and if in 
combination they provide a reliable and valid measure of 
patient-reported outcome post-PCI.
The finding of this study that feeling unhappy was the 
most influential symptom or feeling in patients’ assess-
ment of their health outcome following PCI is consis-
tent with previous studies. Epidemiological studies 
report that 25%–50% of people experience depression 
Table 2 Demographic and clinical characteristics of 
participating patients
Characteristic
Study participants 
(n=138)
Male, n (%) 102 (73.9)
Age, mean SD 67 (10.8)
Living alone, n (%) 33 (23.9)
Education, n (%)
  Primary school 8 (5.8)
  High school 39 (28.3)
  Trade/certificate/diploma 47 (34.1)
  University 44 (31.9)
Working status, n (%)
  Full-time 32 (23.2)
  Part-time/casual 16 (11.6)
  Retired 70 (50.7)
  No paid work 20 (14.5)
Privately insured, n (%) 80 (58.0)
Time since PCI (months), mean (SD) 4.33 (2.0)
First PCI, n (%) 96 (69.6)
Type of procedure 
  Emergency procedure, n (%) 86 (62.3)
  Elective procedure, n (%) 47 (34.1)
  Do not know, n (%) 5 (3.6)
Top five comorbidities, n (%)
  Arthritis 43 (31.2)
  Diabetes 35 (25.4)
  Depression 23 (16.7)
  Asthma 20 (14.5)
  Macular degeneration or cataracts 18 (13.0)
Health rating, n (%)
  Poor 2 (1.5)
  Fair 28 (20.3)
  Good 42 (30.4)
  Very good 46 (33.3)
  Excellent 19 (13.8)
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and 24%–72% experience anxiety in the 3 months 
after PCI.28–30 The feelings of depression are prevalent, 
and they are associated with an increased risk of mortality 
and revascularisation post-PCI.31 The reason for these 
psychological symptoms are posited to be due to lack of 
knowledge and information provided about the disease 
and the procedure, low health literacy, feeling physi-
cally unwell after a PCI and fears of adverse outcomes.28 
Prior research has also indicated that the PCI may lead to 
increased sympathetic activity and inflammation, which 
may lead to anxiety and depression.28 These feelings 
may affect a patient’s daily life and work activities and 
also impact on perceptions of overall satisfaction of the 
treatment. Assessing feelings of anxiety and depression 
following a PCI may assist in the identification of unmet 
care needs and facilitate discussions about need for 
psychological interventions for some patients. One novel 
finding by this study was that patients resonated with the 
wording of being unhappy over depression, which may 
indicate a preference for non-clinical terminology to 
describe their emotional states. Prior research has indi-
cated that lay accounts of mental health do not tend 
to recognise emotional distress as a medical problem, 
rather the feelings are seen as part of normal life.32 
Most existing PROMs focus on depression as opposed to 
feeling unhappy. By example, of the three PROMs recom-
mended in the ICHOM Standard Set for CAD, none 
include questions about happiness, but they do contain 
questions about depression.12 The Set identifies depres-
sion as one of the outcomes that matters most to cardiac 
patients and recommends this be assessed via the Patient 
Health Questionnaire.12 The findings of this study suggest 
happiness may be the more meaningful feeling to assess 
than depression.
Table 3 Conditional logit regression results from discrete-choice experiment
Symptoms and feelings Level OR 95% CI P values
Pain or discomfort Never Reference level
Some of the time 0.78 (0.64 to 0.94) 0.01
Most of the time 0.51 (0.42 to 0.63) <0.0001
Shortness of breath Never Reference level
Some of the time 1.12 (0.93 to 1.36) 0.24
Most of the time 0.65 (0.54 to 0.79) <0.0001
Concerned or worried 
about  heart problem 
Never Reference level
Some of the time 0.85 (0.70 to 1.03) 0.09
Most of the time 0.52 (0.43 to 0.63) <0.0001
Tiredness Never Reference level
Some of the time 1.03 (0.86 to 1.24) 0.75
Most of the time 0.61 (0.51 to 0.73) <0.0001
Confidence to do usual 
activities 
Never Reference level
Some of the time 0.64 (0.52 to 0.78) <0.0001
Most of the time 0.51 (0.41 to 0.63) <0.0001
Physically able to do usual 
activities 
Never Reference level
Some of the time 0.87 (0.71 to 1.06) 0.18
Most of the time 0.48 (0.39 to 0.6) <0.0001
Feeling unhappy Never Reference level
Some of the time 0.89 (0.73 to 1.07) 0.22
Most of the time 0.42 (0.34 to 0.51) <0.0001
Trouble falling or staying 
asleep 
Never Reference level
Some of the time 0.84 (0.69 to 1.03) 0.09
Most of the time 0.59 (0.49 to 0.71) <0.0001
Dizziness or light-
headedness 
Never Reference level
Some of the time 0.86 (0.73 to 1.03) 0.11
Most of the time 0.51 (0.42 to 0.62) <0.0001
Bruising Never Reference level
Some of the time 1.01 (0.85 to 1.21) 0.87
Most of the time 0.81 (0.67 to 0.99) 0.04
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It was an important finding of this study that symptom 
and feeling value did not appear to vary across elective 
and emergency patient groups, indicating that PROMs 
that include the eight recommended outcomes are likely 
to be applicable to both patient groups. There is limited 
prior research that has explored the validity of PROMs 
across emergency and elective cardiac patients.
Common symptoms and feelings included in existing 
cardiac-specific PROMs include physical ability, pain, 
depression, concern or worry about heart problems, 
shortness of breath (dyspnoea) and tiredness. These 
symptoms and feelings were ranked highly in the DCE 
by participants, except for shortness of breath, which was 
ranked the second least important item. Patients felt that 
shortness of breath was a less important item following 
PCI, despite shortness of breath being a key clinical 
symptom of heart disease. Shortness of breath has also 
been recommended as a core item for cardiac instru-
ments to measure, which explains its common appear-
ance in previous cardiac PROMs.12 Interestingly, in our 
survey, we questioned patients about pain and discomfort 
when exerting (eg, carrying groceries, climbing, stairs, 
brisk walking), whereas previous PROMs specify the area 
of pain (eg, chest, shoulders, legs).15 During step 2 of this 
study, participants did speak about chest pain (angina); 
however, they identified that angina manifested as pain in 
other areas of the body (jaw, shoulder, arm) and also was 
experienced as ‘discomfort’ rather than pain.23 There-
fore, in order to make the PROM as brief as possible, 
we decided to include only one question about pain and 
make it a generic pain question including the discomfort 
aspect. As PROMs are generally completed by the patients 
themselves to avoid interpretation by a clinician or other 
health provider, it is essential that PROMs are acceptable 
and easily interpretable.
This study has a number of strengths. DCE have an 
advantage over simple ranking methods as they quan-
tify the relative value, as well as order of importance 
of each individual item.33 34 The DCE was initially 
pilot tested with eight patients to gauge whether the 
survey was easy to complete and what adjustments were 
required to improve usability. Our DCE design was both 
orthogonal and balanced, which ensured there was no 
correlation between individual symptoms and feelings 
or overlap between scenarios. The thorough develop-
ment of the DCE, including literature review, focus 
groups and survey piloting, ensured optimal selection 
of symptoms and feelings evaluated in this DCE. After 
completing the DCE, participants were also asked if 
they felt any key symptoms or feelings were missing 
from the list and none was identified. The engagement 
of clinicians and registry staff in both the design and 
interpretation of the findings has aimed to optimise 
the utility of the PROM. However, there were some 
limitations of the design to be considered. The DCE 
asked participants to consider 16 choice sets each with 
two different health scenarios containing 10 symptoms 
and feelings per scenario. A large amount of informa-
tion can be difficult to simultaneously consider and, 
as such, participants may not have fully deliberated all 
information or symptoms and feelings. Similar surveys 
have also included a large number of symptoms and 
feelings (e.g., the survey by Norman et al18 included 11 
symptoms and feelings, and a survey by Rowen et al24 
Figure 3 Conditional logit regression results from discrete-choice experiment (unadjusted vs adjusted for age and gender).
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included 8 symptoms and feelings). It is possible that 
there may be interaction in preferences for some of 
the symptoms and feelings, for example, tiredness and 
sleep. Nevertheless, the study design selected choice 
sets assuming an additive model, meaning that inter-
action effects cannot be accurately estimated. A low 
response rate was observed in this study (13%). Still, 
participant characteristics were found to be similar 
to the VCOR population and thus likely to be repre-
sentative of this clinical group, although they may 
differ in terms of other unmeasured characteristics. 
The low response rate also limited statistical power to 
undertake subgroup analyses of individual conditions 
(such as angina, myocardial infarct). Participants with 
different conditions may perceive such factors differ-
ently, warranting further investigation in future studies.
COnCLusIOn
Understanding the symptoms and feelings most 
valued by patients following PCI provides valuable 
data to inform the establishment a new PROM for 
patients undergoing PCI. The results from this study 
have been used as part of a larger mixed-methods 
project to develop a PROM. The DCE analysis led to the 
10-item PROM being reduced to 8 symptoms and feel-
ings. DCEs are a useful method to adopt in the develop-
ment of PROMs. The symptoms and feelings identified 
by this study will be tested in further analysis to confirm 
which combination of items should be included in a 
new PROM for patients follow PCI.
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